Kaili Catalyst & New Materials (688269)
Search documents
凯立新材:选举曾永康先生为公司董事长
Zheng Quan Ri Bao Wang· 2025-08-14 13:15
证券日报网讯8月14日晚间,凯立新材发布公告称,选举曾永康先生为公司董事长。 ...
凯立新材(688269.SH)发布半年度业绩,归母净利润6120万元,同比增长30.83%
智通财经网· 2025-08-14 12:18
智通财经APP讯,凯立新材(688269.SH)披露2025年半年度报告,报告期公司实现营收10.14亿元,同比 增长24.86%;归属于上市公司股东的净利润6120万元,同比增长30.83%;扣非净利润6329万元,同比增长 48.74%;基本每股收益0.47元。 ...
凯立新材:2025年半年度净利润约6120万元,同比增加30.83%
Mei Ri Jing Ji Xin Wen· 2025-08-14 11:53
Core Insights - The company reported a significant increase in revenue and net profit for the first half of 2025, indicating strong financial performance [2] Financial Performance - The company's revenue for the first half of 2025 was approximately 1.014 billion yuan, representing a year-on-year increase of 24.86% [2] - The net profit attributable to shareholders was around 61.2 million yuan, showing a year-on-year growth of 30.83% [2] - Basic earnings per share reached 0.47 yuan, which is an increase of 30.56% compared to the previous year [2]
凯立新材(688269) - 关于拟注销控股子公司暨关联交易的公告
2025-08-14 11:15
证券代码:688269 证券简称:凯立新材 公告编号:2025-027 西安凯立新材料股份有限公司 关于拟注销控股子公司暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 一、本次交易情况概述 凯立新材于 2023 年 4 月 26 日召开第三届董事会第十次会议,会议审议 通过了《关于公司与关联方共同投资成立控股子公司暨关联交易的议案》, 公司与云龙铂顺再生资源有限公司、控股股东西北有色金属研究院控制的西 安西色院四号企业管理合伙企业(以下简称"西色院四号")及标的公司员 工持股平台共同出资 10,000 万元人民币设立凯立铂翠,其中公司认缴出资 3,500 万元人民币,认缴比例为 35%,凯立铂翠纳入凯立新材合并报表范围。 具体内容详见公司于 2023 年 4 月 28 日披露于上海证券交易所网站的《对外 投资暨关联交易公告》(公告编号:2023-020)。 截至目前,基于市场环境、宏观环境、合作方等多方面因素影响,凯立 铂翠未来经营状况不确定性上升。凯立铂翠未实际开展经营活动,股东均未 2 ...
凯立新材(688269) - 独立董事专门会议2025年第二次会议决议
2025-08-14 11:15
西安凯立新材料股份有限公司 西安凯立新材料股份有限公司 第四届独立董事专门会议 2025 年第二次会议决议 西安凯立新材料股份有限公司(以下简称"公司")第四届独立董事专门会 议 2025 年第二次会议于 2025年 8 月 13 目(星期三)9:30 在西安经济技术开 发区高铁新城尚林路 4288 号凯立新材综合楼办公室以现场结合通讯的方式召开。 会议通知已于 2025年 8 月 10 日通过书面及通讯的方式送达各位独立董事。本次 会议应出席独立董事3人,实际出席独立董事3人。 会议由独立董事张宁生主持。会议召开符合有关法律、法规、规章和《公 司章程》的规定。经各位独立董事认真审议,会议形成了如下决议: 一、审议通过《关于注销控股子公司凯立铂翠暨关联交易的议案》 经审议,独立董事认为:根据公司实际经营情况及未来业务发展规划,鉴于 公司控股子公司凯立铂翠(铜川)金属材料有限公司自成立以后并未实际开展业 务,为优化资源配置及资产结构,降低管理成本,提高运营管理效率,经审慎研 究,同意注销凯立铂翠(铜川)金属材料有限公司并授权董事会指定人选全权办 理相关注销手续。根据《中华人民共和国公司法》及《西安凯立新材料股份 ...
凯立新材(688269) - 2025年度提质增效重回报专项行动方案的半年度评估报告
2025-08-14 11:15
西安凯立新材料股份有限公司 2025 年度提质增效重回报专项行动方案的半年度评估报告 为践行以"投资者为本"的上市公司发展理念,深入落实上海证券交易所关 于上市公司开展"提质增效重回报"专项行动公开倡议,切实维护公司全体股东 利益,促进公司高质量发展。西安凯立新材料股份有限公司(以下简称"公司" 或"凯立新材")于 2025 年 4 月 21 日发布《2024 年度"提质增效重回报"行 动方案评估报告及 2025 年度行动方案》(以下简称"行动方案"),为公司 2025 年度提质增效重回报行动制定出明确的工作方向。 2025 年上半年,行动方案主要举措的落实(进展)及成效情况如下: 一、 聚焦催化主业,提升经营质量 公司是一家专注于"催化"的高科技企业,长期以来,以国家、行业、市场 对催化材料与技术的重大需求为主攻方向,以工程化、产业化为目标,发展安全、 高效、绿色、环保的催化材料与催化应用技术,多个型号催化材料打破进口垄断, 实现进口替代与技术迭代,市场占有率不断提升。公司始终坚持创新驱动发展战 略和"绿色催化,造福人类"的理念,致力于将公司打造成我国催化材料与技术 的研究开发、生产制造的领先者,科技创新的 ...
凯立新材(688269) - 关于董事长退休离任及选举职工代表董事、补选董事长的公告
2025-08-14 11:15
证券代码:688269 证券简称:凯立新材 公告编号:2025-026 西安凯立新材料股份有限公司 关于董事长退休离任及选举职工代表董事、 补选董事长的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 西安凯立新材料股份有限公司(以下简称"公司""凯立新材")董事会于近 日收到张之翔先生的书面辞职报告。张之翔先生由于到龄退休,申请辞去公 司董事长、董事、董事会下设专门委员会委员职务,并不再担任公司法定代 表人。上述辞呈自送达公司董事会之日生效,张之翔先生将继续认定为公司 核心技术人员,继续支持公司研发工作。 公司于 2025 年 8 月 13 日召开了 2025 年第一次职工代表大会,审议通过了 《关于公司选举职工代表董事的议案》,选举高武先生担任公司职工代表董 事;召开了第四届董事会第八次会议,审议通过了《关于选举董事长的议案》 《关于调整董事会专门委员会委员的议案》,选举曾永康先生为公司董事长, 并相应调整专门委员会委员。上述人员任期与本届董事会任期一致。 二、离任对公司的影响 张之翔先生已妥善完成工作 ...
凯立新材(688269) - 2025 Q2 - 季度财报
2025-08-14 11:05
[Company Profile and Key Financial Indicators](index=7&type=section&id=Company%20Profile%20and%20Key%20Financial%20Indicators) This section provides an overview of the company's basic information and presents its key accounting data and financial performance indicators [Company Overview](index=7&type=section&id=Company%20Overview) Xi'an Kaili New Materials Co., Ltd. (Kaili New Materials, 688269) is a new materials company led by Zeng Yongkang, registered and operating in Xi'an Economic and Technological Development Zone, Shaanxi Province - Company's Chinese name is Xi'an Kaili New Materials Co., Ltd., stock code **688269**, listed on the STAR Market of Shanghai Stock Exchange[13](index=13&type=chunk)[16](index=16&type=chunk) - Mr. Zeng Yongkang has been appointed as the legal representative of the company[13](index=13&type=chunk) [Key Accounting Data and Financial Indicators](index=8&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) During the reporting period, the company achieved operating revenue of **1.014 billion yuan**, a **24.86%** increase, and net profit attributable to parent of **61.2 million yuan**, up **30.83%**, driven by increased catalyst sales and optimized business structure, though net cash flow from operating activities significantly decreased to **-91.18 million yuan** due to increased receivables and raw material purchases Key Accounting Data (yuan) | Key Accounting Data | Current Period (Jan-Jun) | Prior Period | Year-on-Year Change (%) | | :--- | :--- | :--- | :--- | | **Operating Revenue** | 1,014,440,234.28 | 812,448,045.42 | 24.86 | | **Net Profit Attributable to Shareholders of Listed Company** | 61,195,291.25 | 46,776,124.61 | 30.83 | | **Net Profit Attributable to Shareholders of Listed Company After Deducting Non-Recurring Gains and Losses** | 63,294,359.78 | 42,552,326.99 | 48.74 | | **Net Cash Flow from Operating Activities** | -91,179,720.04 | 35,190,791.64 | -359.10 | Key Financial Indicators | Key Financial Indicators | Current Period (Jan-Jun) | Prior Period | Year-on-Year Change (%) | | :--- | :--- | :--- | :--- | | **Basic Earnings Per Share (yuan/share)** | 0.47 | 0.36 | 30.56 | | **Basic Earnings Per Share After Deducting Non-Recurring Gains and Losses (yuan/share)** | 0.48 | 0.33 | 45.45 | | **Weighted Average Return on Net Assets (%)** | 5.86 | 4.62 | Increased by 1.24 percentage points | | **R&D Investment as Percentage of Operating Revenue (%)** | 2.34 | 2.72 | Decreased by 0.38 percentage points | - Operating revenue growth primarily due to a **122.33% year-on-year increase** in overall catalyst product sales, with sales in the pharmaceutical and basic chemical sectors growing by **49.26%** and **185.54%** respectively[19](index=19&type=chunk) - Net cash flow from operating activities significantly decreased by **359.10%**, mainly due to increased accounts receivable from expanded sales and higher raw material procurement expenses to meet production orders[22](index=22&type=chunk) [Management Discussion and Analysis](index=10&type=section&id=Management%20Discussion%20and%20Analysis) This section provides an in-depth discussion of the company's industry position, operational performance, core competencies, and key risk factors [Industry and Main Business](index=10&type=section&id=Description%20of%20Industry%20and%20Main%20Business%20During%20the%20Reporting%20Period) The company, a leading precious metal catalyst enterprise in fine chemicals, expanded into basic chemicals and environmental new energy, achieving significant sales growth of **49.26%** in pharmaceuticals, **185.54%** in basic chemicals, and **1497.06%** in environmental new energy - The company is a leader and technology pioneer in precious metal catalysts within the fine chemical sector, with business synergistically developing around "catalyst preparation and catalytic application technology", forming three major business segments: R&D and production, technology development, and recycling and reprocessing[27](index=27&type=chunk) - During the reporting period, the company achieved significant sales growth across all major business areas: - **Pharmaceutical Sector**: Sales increased by **49.26%** year-on-year, primarily due to increased demand from core customers and enhanced market share[29](index=29&type=chunk) - **Basic Chemical Sector**: Sales increased by **185.54%** year-on-year, mainly benefiting from a **113.22%** increase in PVC mercury-free catalyst sales and new product promotion[30](index=30&type=chunk) - **Environmental New Energy Sector**: Sales surged by **1497.06%** year-on-year, primarily due to significant progress in hydrogen energy catalysts and establishing partnerships with leading water electrolysis hydrogen production enterprises[32](index=32&type=chunk) [Discussion and Analysis of Operations](index=12&type=section&id=Discussion%20and%20Analysis%20of%20Operations) In H1 2025, the company made significant progress in strategy, R&D, marketing, and production, forming a "three locations, four zones" synergistic development pattern, advancing R&D digitalization, expanding market reach, and enhancing operational efficiency through automation - **Strategic Layout**: The company has formed a "Caotan, Jingwei, Tongchuan, Binzhou" three locations, four zones synergistic development pattern. The main construction of the Binzhou Kaitai Hydrogenated Nitrile Butadiene Rubber industrialization project has been completed and entered the commissioning phase[35](index=35&type=chunk) - **Technology R&D**: In H1 2025, **23 new invention patent applications** were filed, with a cumulative total of **191 authorized patents**. The company strengthened R&D digitalization, utilizing AI simulation and prediction to guide catalyst R&D[36](index=36&type=chunk)[37](index=37&type=chunk) - **Market Marketing**: While consolidating its leading position in fine chemicals, sales in the basic chemical sector increased by **185.54%** year-on-year. The company is also accelerating its global layout, actively collaborating with overseas customers[38](index=38&type=chunk)[39](index=39&type=chunk) - **Production Operations**: Multiple automated demonstration production lines were established, and the automation upgrade of the PVC mercury-free catalyst carbon carrier treatment production line was completed, enhancing operational efficiency[39](index=39&type=chunk)[40](index=40&type=chunk) [Analysis of Core Competencies](index=14&type=section&id=Analysis%20of%20Core%20Competencies%20During%20the%20Reporting%20Period) The company's core competencies span six areas: institutional mechanisms, technology R&D, products, talent, brand and customer base, and service advantages, with continuous R&D investment, **23.75 million yuan** in expensed R&D in H1, and **173** cumulative invention patents, focusing on cutting-edge projects to address "bottleneck" issues and achieve import substitution - Company's core competencies include: 1. **Institutional Mechanism Advantage**: State-controlled background with core employee stock ownership[43](index=43&type=chunk) 2. **Technology and R&D Advantage**: Synergistic development of catalyst and catalytic application technology, possessing national-level research platforms[44](index=44&type=chunk) 3. **Product Advantage**: Comprehensive product range with excellent performance, covering fine chemicals, basic chemicals, energy, and environmental protection[46](index=46&type=chunk) 4. **Talent Advantage**: Stable and professional core management and technical team[47](index=47&type=chunk) 5. **Brand and Customer Advantage**: Nearly a thousand users, including a hundred listed companies, with high brand recognition[49](index=49&type=chunk) 6. **Service Advantage**: Provides integrated full-process services from R&D and production to recycling[49](index=49&type=chunk) - New progress in core technologies, including the activation of advanced scientific research systems introducing AI simulation and prediction, development of new platinum-carbon and ruthenium-based catalysts, breakthroughs in precious metal valence state control technology, and collaboration with Dalian Institute of Chemical Physics, Chinese Academy of Sciences on single-atom catalysts[50](index=50&type=chunk) R&D Investment | R&D Investment | Current Period (yuan) | Prior Period (yuan) | Change (%) | | :--- | :--- | :--- | :--- | | **Expensed R&D Investment** | 23,753,649.66 | 22,120,503.73 | 7.38 | | **Total R&D Investment** | 23,753,649.66 | 22,120,503.73 | 7.38 | | **Total R&D Investment as Percentage of Operating Revenue (%)** | 2.34 | 2.72 | Decreased by 0.38 percentage points | - As of the end of the reporting period, the company has cumulatively obtained **173 invention patents** and **16 utility model patents**. During the reporting period, **23 new invention patent applications** were filed, and **4 were granted**[54](index=54&type=chunk)[55](index=55&type=chunk) [Risk Factors](index=26&type=section&id=Risk%20Factors) The company faces core risks from rapid technological iteration and competitive gaps, operational risks from volatile precious metal prices and high capital occupation, and financial risks including accounts receivable impairment and gross margin fluctuations, alongside industry-specific precious metal resource scarcity and macroeconomic policy changes - **Core Competitiveness Risk**: The industry experiences rapid technological upgrades and iterations; if the company fails to continuously maintain technological advancement, it may face risks of declining competitiveness[69](index=69&type=chunk)[70](index=70&type=chunk) - **Operational Risk**: Platinum group precious metals, as primary raw materials, are subject to significant price fluctuations and high costs, accounting for over **90%** of production costs, posing challenges to the company's cost and inventory management. Downstream pharmaceutical customers are affected by policies like "4+7" volume-based procurement, which may demand cost reductions or new process development, placing higher requirements on the company's products[71](index=71&type=chunk)[72](index=72&type=chunk) - **Financial Risk**: At the end of the reporting period, the book value of accounts receivable increased, intensifying working capital occupation and bad debt risks. Concurrently, changes in business structure and raw material costs may lead to gross margin fluctuations[74](index=74&type=chunk) - **Industry Risk**: China's platinum group metal resources are scarce, primarily relying on imports; if international political factors affect supply, it will significantly impact the company's production and operations[75](index=75&type=chunk) [Analysis of Key Operating Performance](index=29&type=section&id=Key%20Operating%20Performance%20During%20the%20Reporting%20Period) During the reporting period, operating revenue and cost increased by **24.86%** and **22.58%** respectively, while financial expenses surged by **238.97%** due to increased short-term borrowings for raw material procurement; accounts receivable and financing receivables grew significantly, reflecting expanded sales and enhanced collection management, with Tongchuan Kaili contributing significantly to profit Key Operating Data (yuan) | Item | Current Period | Prior Period | Change (%) | | :--- | :--- | :--- | :--- | | **Operating Revenue** | 1,014,440,234.28 | 812,448,045.42 | 24.86 | | **Operating Cost** | 892,657,605.31 | 728,200,539.69 | 22.58 | | **Financial Expenses** | 6,970,526.86 | 2,056,372.86 | 238.97 | | **Net Cash Flow from Operating Activities** | -91,179,720.04 | 35,190,791.64 | -359.10 | - Financial expenses increased by **238.97%** year-on-year, primarily due to increased short-term borrowings for raw material procurement during the reporting period, leading to higher interest expenses[79](index=79&type=chunk) Assets/Liabilities Items (yuan) | Asset/Liability Item | Current Period End | Prior Period End | Change (%) | | :--- | :--- | :--- | :--- | | **Accounts Receivable** | 227,181,414.79 | 155,833,042.87 | 45.79 | | **Accounts Receivable Financing** | 105,160,602.64 | 56,777,284.20 | 85.22 | | **Long-term Borrowings** | 150,250,215.91 | 115,000,000.00 | 30.65 | - As of the end of the reporting period, the company's total restricted assets amounted to **405 million yuan**, mainly comprising fixed assets, intangible assets, and construction in progress pledged for borrowings[84](index=84&type=chunk)[85](index=85&type=chunk) [Corporate Governance, Environment, and Society](index=36&type=section&id=Corporate%20Governance%2C%20Environment%2C%20and%20Society) This section details changes in the company's board, senior management, and core technical personnel [Changes in Directors, Supervisors, Senior Management, and Core Technical Personnel](index=36&type=section&id=Changes%20in%20Company%20Directors%2C%20Senior%20Management%2C%20and%20Core%20Technical%20Personnel) During the reporting period, the company experienced several senior personnel changes, including Mr. Zhang Zhixiang's retirement as Chairman, succeeded by Mr. Zeng Yongkang, and Ms. Wang Shihong's resignation as CFO and Board Secretary, succeeded by Mr. Zeng Lihui, with no changes in core technical personnel - Mr. Zhang Zhixiang resigned as Chairman due to retirement but continues to serve as a core technical personnel[93](index=93&type=chunk) - Mr. Zeng Yongkang was elected as the new Chairman and became the company's legal representative[93](index=93&type=chunk) - Mr. Zeng Lihui was appointed as Deputy General Manager, Chief Financial Officer, and Board Secretary[93](index=93&type=chunk)[94](index=94&type=chunk) [Significant Matters](index=38&type=section&id=Significant%20Matters) This section outlines the fulfillment of commitments, significant related party transactions, and major contracts and their performance [Fulfillment of Commitments](index=38&type=section&id=Fulfillment%20of%20Commitments) During the reporting period, the company's actual controller, shareholders, related parties, and the company itself strictly adhered to all commitments made during the initial public offering, including share lock-up, holding intentions, avoidance of horizontal competition, and standardization of related party transactions, with no violations - Commitments made by the company's controlling shareholder Northwest Institute, directors, senior management, and core technical personnel, such as share lock-up, were timely and strictly fulfilled during or continuing into the reporting period[101](index=101&type=chunk)[102](index=102&type=chunk)[103](index=103&type=chunk) [Significant Related Party Transactions](index=59&type=section&id=Significant%20Related%20Party%20Transactions) During the reporting period, the company engaged in daily operational related party transactions, including sales of products and services totaling **23.65 million yuan** to Xi'an Taijin New Energy Technology Co., Ltd. and **4.15 million yuan** to Western Metal Materials Co., Ltd., all within the estimated amounts Related Party Transaction Categories | Related Party Transaction Category | Related Party | Estimated Amount (million yuan) | Actual Amount During Reporting Period (million yuan) | | :--- | :--- | :--- | :--- | | **Sales of Products, Goods, and Services to Related Parties** | Xi'an Taijin New Energy Technology Co., Ltd. and its controlled companies | 6,000.00 | 2,365.39 | | | Western Metal Materials Co., Ltd. and its controlled companies | 4,000.00 | 414.91 | | | Northwest Institute for Non-ferrous Metal Research, the company's controlling shareholder, and its controlled companies | 500.00 | 230.14 | | **Acceptance of Services from Related Parties** | Northwest Institute for Non-ferrous Metal Research, the company's controlling shareholder, and its controlled companies | 285.00 | 133.64 | [Significant Contracts and Their Fulfillment](index=61&type=section&id=Significant%20Contracts%20and%20Their%20Fulfillment) During the reporting period, the company provided joint liability guarantees totaling up to **400 million yuan** for its wholly-owned subsidiary Tongchuan Kaili, with a remaining guarantee balance of **81.75 million yuan** at period-end, representing **8.11%** of net assets, all within approved limits and without overdue external guarantees - The company provided two guarantees for its wholly-owned subsidiary Tongchuan Kaili, totaling **130 million yuan**, for working capital and fixed asset borrowings[130](index=130&type=chunk) - At the end of the reporting period, the total guarantee balance for subsidiaries was **81.75 million yuan**, representing **8.11%** of the company's net assets[130](index=130&type=chunk) [Share Changes and Shareholder Information](index=65&type=section&id=Share%20Changes%20and%20Shareholder%20Information) This section details the company's shareholder structure and key shareholder information [Shareholder Information](index=65&type=section&id=Shareholder%20Information) As of the end of the reporting period, the company had **5,848** common shareholders, with the top ten shareholder structure remaining stable, and controlling shareholder Northwest Institute for Non-ferrous Metal Research holding **25.71%**, alongside core management and institutional investors like social security and pension funds - As of the end of the reporting period, the company had a total of **5,848** common shareholders[136](index=136&type=chunk) Shareholder Information | Shareholder Name | Shares Held at Period End | Percentage (%) | | :--- | :--- | :--- | | Northwest Institute for Non-ferrous Metal Research | 33,600,000 | 25.71 | | Zhang Zhixiang | 5,506,632 | 4.21 | | Huatai-PineBridge Fund Management Co., Ltd. - Social Security Fund 17022 Portfolio | 3,390,598 | 2.59 | | Basic Pension Insurance Fund 16032 Portfolio | 1,996,684 | 1.53 | | Wang Pengbao | 1,755,800 | 1.34 | [Financial Report](index=70&type=section&id=Financial%20Report) This section presents the company's consolidated financial statements and selected notes, providing a detailed view of its financial position and performance [Consolidated Financial Statements](index=70&type=section&id=Consolidated%20Financial%20Statements) As of June 30, 2025, the company's total assets were **2.164 billion yuan**, up **5.50%** from the beginning of the period, with total liabilities of **1.114 billion yuan**, operating revenue of **1.014 billion yuan**, and net profit of **61.13 million yuan**, while operating cash flow was a net outflow of **91.18 million yuan** and financing cash flow a net inflow of **83.54 million yuan** Balance Sheet Items (yuan) | Balance Sheet Item | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | **Total Assets** | 2,164,106,653.29 | 2,051,340,758.70 | | **Total Liabilities** | 1,114,456,952.16 | 999,321,050.54 | | **Total Equity Attributable to Parent Company Owners** | 1,007,544,973.82 | 1,013,485,099.31 | Income Statement Items (yuan) | Income Statement Item | H1 2025 | H1 2024 | | :--- | :--- | :--- | | **Total Operating Revenue** | 1,014,440,234.28 | 812,448,045.42 | | **Total Operating Cost** | 949,209,029.82 | 774,611,538.17 | | **Total Profit** | 69,075,853.22 | 51,426,288.86 | | **Net Profit** | 61,125,409.71 | 46,747,372.85 | Cash Flow Statement Items (yuan) | Cash Flow Statement Item | H1 2025 | H1 2024 | | :--- | :--- | :--- | | **Net Cash Flow from Operating Activities** | -91,179,720.04 | 35,190,791.64 | | **Net Cash Flow from Investing Activities** | -77,892,281.49 | -204,531,931.44 | | **Net Cash Flow from Financing Activities** | 83,535,800.37 | 139,032,604.15 | [Notes to Financial Statements (Excerpt)](index=117&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) Financial statement notes detail account composition and changes, including **230 million yuan** in cash and equivalents (with **12.1 million yuan** restricted), **227 million yuan** in accounts receivable (up **45.79%**), **338 million yuan** in inventory, and operating revenue primarily from catalyst sales, with **23.75 million yuan** in expensed R&D - Cash and equivalents at period-end totaled **230 million yuan**, of which **12.1 million yuan** was restricted as bank guarantee deposits[286](index=286&type=chunk) - Accounts receivable at period-end had a book balance of **240 million yuan**, with a book value of **227 million yuan** after deducting **12.47 million yuan** for bad debt provisions[295](index=295&type=chunk)[298](index=298&type=chunk) Operating Revenue Composition (yuan) | Operating Revenue Composition | Revenue (yuan) | Cost (yuan) | | :--- | :--- | :--- | | **Main Business** | 941,830,136.94 | 822,391,027.08 | | Of which: Catalyst Sales | 873,814,904.71 | 792,148,143.05 | | Catalyst Processing | 67,676,536.82 | 30,160,369.20 | | **Other Business** | 72,610,097.34 | 70,266,578.23 | | **Total** | 1,014,440,234.28 | 892,657,605.31 | - Total R&D expenses during the reporting period were **23,753,649.66 yuan**, primarily comprising employee compensation (**10.78 million yuan**) and material costs (**6.52 million yuan**), all expensed[419](index=419&type=chunk)[446](index=446&type=chunk)
凯立新材(688269.SH):董事长张之翔退休离任
Ge Long Hui A P P· 2025-08-14 11:00
格隆汇8月14日丨凯立新材(688269.SH)公布,董事会于近日收到张之翔先生的书面辞职报告。张之翔先 生由于到龄退休,申请辞去公司董事长、董事、董事会下设专门委员会委员职务,并不再担任公司法定 代表人。上述辞呈自送达公司董事会之日生效,张之翔先生将继续认定为公司核心技术人员,继续支持 公司研发工作。 公司于2025年8月13日召开了2025年第一次职工代表大会,审议通过了《关于公司选举职工代表董事的 议案》,选举高武先生担任公司职工代表董事;召开了第四届董事会第八次会议,审议通过了《关于选 举董事长的议案》《关于调整董事会专门委员会委员的议案》,选举曾永康先生为公司董事长,并相应 调整专门委员会委员。上述人员任期与本届董事会任期一致。 ...
凯立新材(688269.SH):上半年净利润6119.5万元 同比增长30.83%
Ge Long Hui A P P· 2025-08-14 11:00
Group 1 - The company Kaili New Materials (688269.SH) reported a revenue of 1.014 billion yuan for the first half of the year, representing a year-on-year growth of 24.86% [1] - The net profit attributable to shareholders of the listed company was 61.195 million yuan, an increase of 30.83% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 63.29 million yuan, showing a year-on-year growth of 48.74% [1]